{
    "nctId": "NCT03109990",
    "briefTitle": "A Pilot Study to Evaluate the Impact of Dexmedetomidine on Breast Cancer Recurrence After Surgery",
    "officialTitle": "A Pilot Study to Evaluate the Impact of Dexmedetomidine on Postoperative Tumor Recurrence in Patients With Primary Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 148,
    "primaryOutcomeMeasure": "study feasibility",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* ASA grade I-III\n* Age range of 18 to75\n* Patients diagnosed primary breast cancer\n* Patients will have elective mastectomy\n\nExclusion Criteria:\n\n* with history of breast operation\n* Patients diagnosed with inflammatory breast\n* Severe mental or physical illnesses(like liver, renal, brain or lung disease)\n* with history of opioid addiction\n* Patients diagnosed metastatic breast cancer\n* Contradictions or an allergy to Dexmedetomidine",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}